Has Nicholas Evangelidis received payments from drug or device companies?

Yes. Drug and device makers reported $2,258 in general payments to Nicholas Evangelidis across 133 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Nicholas Evangelidis did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Nicholas Evangelidis come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Nicholas Evangelidis

Psychiatry · Lawrence, KSNPI 1386965507

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.7% of the total across 133 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Supernus Pharmaceuticals, Inc. at 30.7% of the total.

$2,258in general payments, 2019–2025

Across 133 payments — averaging $16.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Supernus Pharmaceuticals, Inc.$694
Corium, LLC$275
Neurocrine Biosciences, Inc.$202
Takeda Pharmaceuticals U.S.A., Inc.$178
Collegium Pharmaceutical, Inc.$137
Teva Pharmaceuticals USA, Inc.$132
plus $640 from 13 others

What the payments were for

Food & beverage$2,252100%
Education$70%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Supernus Pharmaceuticals, Inc.	32	$694
Corium, LLC	18	$275
Neurocrine Biosciences, Inc.	8	$202
Takeda Pharmaceuticals U.S.A., Inc.	16	$178
Collegium Pharmaceutical, Inc.	18	$137
Teva Pharmaceuticals USA, Inc.	7	$132
Ironshore Pharmaceuticals Inc.	6	$100
Otsuka America Pharmaceutical, Inc.	6	$94
Axsome Therapeutics, Inc.	1	$87
Jazz Pharmaceuticals Inc.	5	$84
Sunovion Pharmaceuticals Inc.	3	$47
Noven Therapeutics, LLC	2	$42
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	2	$40
Tris Pharma Inc	2	$38
Sanofi Pasteur Inc.	2	$33
Johnson & Johnson	2	$30
Alkermes, Inc.	1	$17
Idorsia Pharmaceuticals US Inc	1	$14
AbbVie	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

QELBREE$329

How this compares

$2,258 in reported general payments places this provider in the 75th percentile of 259 psychiatry providers in Kansas.

See all psychiatry providers in Kansas →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Lamotrigine	11	$29
Lithium Carbonate ErLithium Carbonate	11	$28
Fluoxetine Hcl	11	$9

Paid to pharmacies, not to this prescriber.

Other psychiatry in Lawrence

Hiten SoniLawrence$11K
Taylor PorterLawrence$8K
Kristin CunninghamLawrence$2K
David WichmanManhattan$613K
Kevin MaysLeawood$548K
Sheldon PreskornWichita$498K
James OwensSalina$433K
Sasha HamdaniOverland Park$104K
Christine GlennKansas City$58K
Heidi OgdenWichita$55K

See the full list for Kansas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →